Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1248-1250
doi: 10.1161/01.ATV.0000027414.34728.1F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durrington, P.N.
Right arrow Articles by Mackness, M.I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durrington, P.N.
Right arrow Articles by Mackness, M.I.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Genetics of cardiovascular disease
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1248.)
© 2002 American Heart Association, Inc.


Editorials

The Hunt for Nutritional and Pharmacological Modulators of Paraoxonase

P.N. Durrington; B. Mackness; M.I. Mackness

From the University Department of Medicine, Manchester Royal Infirmary, Manchester, United Kingdom.

Correspondence to Dr P.N. Durrington, University Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK. E-mail pdurrington@man.ac.uk


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Considerable experimental evidence suggests that lipid peroxides on LDL and their breakdown products are responsible for the physical changes in the LDL particle and the fragmentation of its apolipoprotein B, which permit it to bind to a wide range of high-affinity receptors on cells in the arterial wall, such as endothelial cells, macrophages, and smooth muscle cells, which are key players in atherosclerosis.1 Fat-soluble antioxidant vitamins in vitro delay the oxidation of LDL,2 suggesting that they might have the therapeutic potential to protect against coronary heart disease (CHD). However, now that several clinical trials of antioxidant fat-soluble vitamins have been completed, the reality is that they do not prevent coronary or other atherosclerotic events.2–4 The reasons for this have been reviewed,5 but germane to the issue may be that the protection against oxidation afforded to LDL by fat-soluble antioxidants is relatively short lived, being principally in the extension of the early lag phase in lipid peroxidation (conjugated diene formation) by a matter of minutes. They act as antioxidants only when they are more susceptible to oxidation than the molecules they protect, and once oxidized, they can become pro-oxidants.2 Additionally, erosion of their potential benefit may stem from their effect in increasing cholesteryl ester heteroexchange6,7 which is increasingly being viewed as proatherogenic.8–10 It could explain the amelioration by high-dose antioxidant vitamins of the regression of coronary atheroma induced by lipid-lowering drugs.11

See page 1329

Paraoxonase 1 (PON1), located on HDL, was first shown more than a decade ago to protect in . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Gouedard, R. Barouki, and Y. Morel
Induction of the Paraoxonase-1 Gene Expression by Resveratrol
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2378 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Gouedard, R. Barouki, and Y. Morel
Dietary Polyphenols Increase Paraoxonase 1 Gene Expression by an Aryl Hydrocarbon Receptor-Dependent Mechanism
Mol. Cell. Biol., June 15, 2004; 24(12): 5209 - 5222.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Ferre, J. Camps, J. Fernandez-Ballart, V. Arija, M. M. Murphy, S. Ceruelo, E. Biarnes, E. Vilella, M. Tous, and J. Joven
Regulation of Serum Paraoxonase Activity by Genetic, Nutritional, and Lifestyle Factors in the General Population
Clin. Chem., September 1, 2003; 49(9): 1491 - 1497.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Mackness, P. Durrington, P. McElduff, J. Yarnell, N. Azam, M. Watt, and M. Mackness
Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study
Circulation, June 10, 2003; 107(22): 2775 - 2779.
[Abstract] [Full Text] [PDF]